Patents by Inventor Cheryl Dreyfus

Cheryl Dreyfus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7378388
    Abstract: Methods and kits are provided for manipulating and predicting the reproductive capacity of a female subject. The presence of endogenous neurotrophins and addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF, increase the reproductive capacity of a female patient by binding to receptors on the oocytes and stimulating maturation of the oocytes. Administration of antagonists act as a contraceptive because the antagonists prevent the neurotrophins from binding to oocyte receptors. Neurotrophins may also be used to stimulate the maturation of oocyte in vitro.
    Type: Grant
    Filed: October 5, 2005
    Date of Patent: May 27, 2008
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: David B. Seifer, Robert Shelden, Bo Feng, Cheryl Dreyfus
  • Patent number: 7097984
    Abstract: Methods and kits are provided for manipulating and predicting the reproductive capacity of a female subject. The presence of endogenous neurotrophins and addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF, increase the reproductive capacity of a female patient by binding to receptors on the oocytes and stimulating maturation of the oocytes. Administration of antagonists act as a contraceptive because the antagonists prevent the neurotrophins from binding to oocyte receptors. Neurotrophins may also be used to stimulate the maturation of oocyte in vitro.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: August 29, 2006
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: David B Seifer, Robert Shelden, Bo Feng, Cheryl Dreyfus
  • Publication number: 20060088884
    Abstract: Methods and kits are provided for manipulating and predicting the reproductive capacity of a female subject. The presence of endogenous neurotrophins and addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF, increase the reproductive capacity of a female patient by binding to receptors on the oocytes and stimulating maturation of the oocytes. Administration of antagonists act as a contraceptive because the antagonists prevent the neurotrophins from binding to oocyte receptors. Neurotrophins may also be used to stimulate the maturation of oocyte in vitro.
    Type: Application
    Filed: October 5, 2005
    Publication date: April 27, 2006
    Inventors: David Seifer, Robert Shelden, Bo Feng, Cheryl Dreyfus
  • Publication number: 20030049244
    Abstract: Methods and kits are provided for manipulating and predicting the reproductive capacity of a female subject. The presence of endogenous neurotrophins and addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF, increase the reproductive capacity of a female patient by binding to receptors on the oocytes and stimulating maturation of the oocytes. Administration of antagonists act as a contraceptive because the antagonists prevent the neurotrophins from binding to oocyte receptors. Neurotrophins may also be used to stimulate the maturation of oocyte in vitro.
    Type: Application
    Filed: July 31, 2002
    Publication date: March 13, 2003
    Inventors: David B. Seifer, Robert Shelden, Bo Feng, Cheryl Dreyfus